These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11876460)

  • 1. FDA approves first nucleic acid test for HIV and HCV.
    Infect Control Hosp Epidemiol; 2001 Dec; 22(12):788-9. PubMed ID: 11876460
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleic acid test system approval.
    AIDS Alert; 2002 Jan; 17(1):10. PubMed ID: 11862731
    [No Abstract]   [Full Text] [Related]  

  • 3. Chiron's procleix HIV-1/HCV assay receives FDA approval.
    Expert Rev Mol Diagn; 2002 Mar; 2(2):94. PubMed ID: 11962342
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA issues final guidance on nucleic acid tests.
    AIDS Alert; 2005 Apr; 20(4):46-7. PubMed ID: 15844224
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biotechnology applied to the diagnosis of HIV/hepatitis C co-infection].
    Maroto Vela MC
    An R Acad Nac Med (Madr); 1996; 113(3):643-55; discussion 655-8. PubMed ID: 9124648
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in postmortem blood specimens using infectious disease assays licensed for cadaveric donor screening.
    Greenwald MA; Kerby S; Francis K; Noller AC; Gormley WT; Biswas R; Forshee RA
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA notifications. FDA approves first nucleic acid test to screen for HIV and HCV.
    AIDS Alert; 2002 May; 17(5):66. PubMed ID: 12030219
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis, evaluation, and treatment of HIV/HCV coinfection.
    Tedaldi E; Bean P
    Am Clin Lab; 2001; 20(9):26-32. PubMed ID: 11766416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.
    Makroo RN; Choudhury N; Jagannathan L; Parihar-Malhotra M; Raina V; Chaudhary RK; Marwaha N; Bhatia NK; Ganguly AK
    Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA approves Procleix HIV-1/HCV assay.
    Am Fam Physician; 2002 Apr; 65(8):1693-4. PubMed ID: 11989643
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden.
    Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B
    Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA approves early test.
    AIDS Patient Care STDS; 2006 Nov; 20(11):814. PubMed ID: 17134356
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of procleix HIV/HCV RNA diagnostic assay].
    Song AJ; Zhang CT; Li XH; Li J; Wang YC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):36-8. PubMed ID: 16642216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.